Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01385761 · ClinicalTrials.gov registry record
LMA Unique TM & the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children
A clinical trial of Children, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT01385761 is a study of Children that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 60 participants, below the 357,292-participant average among 14 other Children trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01385761, a study of Children, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the clinical efficacy of the air-Q ILA-SP with the current standard of care, the LMA Unique in anesthetized non-paralyzed pediatric patients.
Conditions Studied
Interventions
- DEVICE Laryngeal Mask Airway
- DEVICE air-QTM Intubating Laryngeal Airway
Study Locations (1)
Illinois
- Childrens Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01385761
The ClinicalTrials.gov registry entry for NCT01385761 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 357,292-participant average among 14 other Children trials with a reported enrollment target (100% lower). The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Children appearing as the primary indexed condition, and to 2 interventions - of which Laryngeal Mask Airway is the first listed.
NCT01385761 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01385761 about?
NCT01385761 is a clinical study titled "LMA Unique TM & the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children". The purpose of this study is to compare the clinical efficacy of the air-Q ILA-SP with the current standard of care, the LMA Unique in anesthetized non-paralyzed pediatric patients.
What is the current status of trial NCT01385761?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2011-06. Estimated completion is 2012-03.
What conditions does trial NCT01385761 study?
This clinical trial studies the following conditions: Children.
What interventions are being tested in trial NCT01385761?
The interventions under investigation include: Laryngeal Mask Airway (DEVICE), air-QTM Intubating Laryngeal Airway (DEVICE).
Who is sponsoring clinical trial NCT01385761?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01385761 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rural Autistic Individuals - Supporting Expression
RECRUITING · NA
-
Physical Activity and Cognitive Development in Children
RECRUITING
-
Cerebral Palsy and the Study of Brain Activity During Motor Tasks
RECRUITING
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
RECRUITING · Phase 3
-
The Pediatric Anesthesia Quality Improvement Project
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.